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Abstract
Severe malaria can trigger acute lung injury characterized by pulmonary edema resulting from increased endothelial
permeability. However, the mechanism through which lung fluid conductance is altered during malaria remains unclear. To
define the role that the scavenger receptor CD36 may play in mediating this response, C57BL/6J (WT) and CD362/2 mice
were infected with P. berghei ANKA and monitored for changes in pulmonary endothelial barrier function employing an
isolated perfused lung system. WT lungs demonstrated a .10-fold increase in two measures of paracellular fluid
conductance and a decrease in the albumin reflection coefficient (salb) compared to control lungs indicating a loss of barrier
function. In contrast, malaria-infected CD362/2 mice had near normal fluid conductance but a similar reduction in salb. In
WT mice, lung sequestered iRBCs demonstrated production of reactive oxygen species (ROS). To determine whether
knockout of CD36 could protect against ROS-induced endothelial barrier dysfunction, mouse lung microvascular endothelial
monolayers (MLMVEC) from WT and CD362/2 mice were exposed to H2O2. Unlike WT monolayers, which showed dose-
dependent decreases in transendothelial electrical resistance (TER) from H2O2 indicating loss of barrier function, CD362/2
MLMVEC demonstrated dose-dependent increases in TER. The differences between responses in WT and CD362/2
endothelial cells correlated with important differences in the intracellular compartmentalization of the CD36-associated Fyn
kinase. Malaria infection increased total lung Fyn levels in CD362/2 lungs compared to WT, but this increase was due to
elevated production of the inactive form of Fyn further suggesting a dysregulation of Fyn-mediated signaling. The
importance of Fyn in CD36-dependent endothelial signaling was confirmed using in vitro Fyn knockdown as well as Fyn2/2
mice, which were also protected from H2O2- and malaria-induced lung endothelial leak, respectively. Our results
demonstrate that CD36 and Fyn kinase are critical mediators of the increased lung endothelial fluid conductance caused by
malaria infection.
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Introduction
Severe malaria, a major source of morbidity and mortality in
the developing world, is frequently complicated by acute
respiratory distress syndrome (ARDS) which is characterized by
increased vascular permeability resulting in pulmonary edema [1].
ARDS has been reported for all five species of Plasmodium that
infect humans and is considered an important predictor of disease
mortality [2]. Despite this, the mechanisms that drive Plasmodium-
mediated pulmonary injury remain poorly understood [2].
The etiological agents of human malaria are vector-borne
protozoan parasites that initially infect liver cells but rapidly
develop to invade and reproduce in host erythrocytes. These
blood-stage parasites produce a number of proteins that are
exported to the surface of the infected red blood cell (iRBC) [3].
For P. falciparium, one of these exported proteins, erythrocyte
membrane protein 1 (PfEMP1), interacts with host ligands
including the scavenger receptor CD36, the adhesion molecules
ICAM1 and PCAM-1 and the extracellular matrix component
chondroitin sulfate A [4,5] on host vascular endothelial cells to
mediate iRBC adherence to vessel walls. The pattern of adherence
is selective in that most sequestered infected iRBCs are found in
the lungs, adipose tissue, brain and placenta [6–8]. The ability to
sequester in the vasculature of certain tissues is thought to be
advantageous to the parasite because it diminishes clearance of
trophozoite- and schizont-containing iRBCs in the spleen and
promotes factors that are beneficial for parasite growth [3,9].
Sequestration in organs such as the lung is not without
consequences, as large numbers of iRBCs in the lung have been
hypothesized to precipitate events that result in lung injury [1].
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Plasmodium berghei ANKA (PbA) infection in C57BL/6 mice
recapitulates many characteristics of human P. falciparum infection
including iRBC sequestration in the lungs [10] with pulmonary
pathology that includes increased protein extravasation [11,12],
pulmonary edema [13] and hemorrhage [11,13]. Work with
synchronized PbA infections has demonstrated that schizont-
containing RBCs selectively adhere to lung microvascular
endothelial cells [10,14,15] and this interaction is dependent on
capillary endothelial cell expression of CD36 [9,10,16]. Interest-
ingly, the PbA genome does not contain any PfEMP1 orthologues.
Recently, it has been demonstrated that the schizont membrane-
associated cytoadherence protein (SMAC) is critical for PbA
schizont-stage parasites to adhere to vascular endothelium via
CD36 [9]. Thus, despite differences in the stages that sequester in
the lungs between P. falciparum (schizonts, trophozoites and
immature gametocytes) and PbA (schizonts only), both species
adhere to the lung vascular endothelium via CD36.
The goal of the work presented here was to take advantage of
the PbA-mouse model and an isolated perfused lung system to
determine the role that CD36 interactions play in the changes to
pulmonary vascular permeability observed during malaria infec-
tion. We found that PbA-infected CD362/2 mice were protected
from the changes in fluid conductance observed in WT animals.
Employing mouse lung microvascular endothelial cell cultures
(MLMVEC), it was determined that CD362/2 endothelial cells
were also protected from reactive oxygen species (ROS)-induced
changes in barrier integrity. In addition, Fyn, a CD36-associated
tyrosine kinase [17,18], was shown to exhibit an altered
intracellular distribution and activation status in CD362/2
LMVECs and to be critical for CD36-mediated increases in
pulmonary endothelial cell fluid conductance during malaria. Our
results suggest that CD36 signaling through Fyn tyrosine kinase
plays a significant role in mediating the detrimental changes in
pulmonary endothelial barrier function during malaria infection.
In addition, the data point to the possibility that parasite- or host-
derived ROS serve to enhance the CD36-mediated increases in
paracellular fluid conductance during malaria. These findings
suggest that targeting of the CD36-iRBC interaction in the lungs
of patients at risk for pulmonary complications could reduce the
severity of malaria-associated acute lung injury.
Results
CD362/2 mice are protected from P. berghei-induced
lung injury
There were no significant differences in the kinetics of blood
parasitemia, weight loss and body temperature changes between
PbA-infected WT and CD362/2 animals (Figure S1). However,
at day 6 post-infection, WT animals had histologic evidence of
lung injury characterized by thickened alveolar septae, patchy
alveolar edema and increased inflammatory cell infiltration, while
the lungs from CD362/2 animals were indistinguishable from
the lungs of uninfected controls (Figure 1A and 1B). The
heightened pathology observed in the WT lungs was associated
with significantly greater numbers of parasites in the lungs by
histology (Figures 1C and 1D) and by flow cytometry of perfused
lungs (Figure S2). These results are consistent with previous
reports that CD36 is a determinant of iRBC adherence in the
lungs [10] and with the hypothesis that CD36-dependent iRBC-
endothelial cell interactions contribute to pulmonary pathology
during malaria.
CD36 contributes to malaria-induced increases in lung
paracellular fluid conductance
To characterize the effect of malaria infection on the pulmonary
endothelial barrier and to determine the contribution of CD36,
WT and CD362/2 mouse lungs were isolated and perfused with
blood from donor mice after 6 days of malaria infection as
described in the Methods. The filtration coefficient (Kf) and
reflection coefficient for albumin (salb) are components of the
Starling equation, a calculation that is commonly employed to
quantify paracellular fluid conductance and the effectiveness of the
protein oncotic pressure gradient established by the endothelial
barrier, respectively [19]. The estimated Kf by our methodology is
a gravimetric measure with potential errors introduced by vascular
volume change as well as circuit leakage or hemorrhage into the
lung [20]. Therefore, we also calculated fluid filtration (Ff) which is
the average rate of erythrocyte-free fluid volume entering the lung
determined from the perfusate hematocrit change normalized to
the time-weighted vascular pressure. In the isolated-perfused lung
system, PbA infection of WT lungs increased the Kf and Ff .10-
fold compared to controls (Figures 2A and 2B) indicating a marked
increase in paracellular fluid conductance. In contrast, the lungs
from PbA-infected CD362/2 mice had markedly attenuated
changes in Kf and Ff indicating near-complete protection from
malaria-induced paracellular hyperpermeability. Furthermore, we
demonstrated a tight correlation between Kf and Ff (R=0.91,
P,0.0001, N= 27; data not shown) confirming the accuracy of
our methods. Malaria infection also decreased salb in the lungs
from both PbA-infected WT and CD362/2 mice demonstrating
a comparable reduction in salb (Figure 2C), suggesting that the
mechanism controlling the protein sieving properties of the
paracellular junctions [19] was CD36-independent.
The observed CD36-associated effects on capillary endothelial
barrier integrity could result from multiple mechanisms. Interac-
tion with the iRBC may induce CD36-mediated signal transduc-
tion events in vascular endothelial cells [21] that cause alterations
in permeability (see below). It is also possible that the tethered
iRBC is a direct or indirect source of factors that enhance the
hyperpermeabilty phenotype. For example, ROS are known to
increase pulmonary microvascular permeability [22,23]. ROS
production has been associated with P. falciparum asexual
development [24,25] and implicated in the pulmonary pathology
associated with severe malarial [26–28]. ROS can also be derived
from resident or recruited mononuclear cells as they clear iRBCs
from the lungs [29]. Here we investigated the possibility that PbA-
infected RBCs were a source of ROS.
Lung sequestered PbA-iRBCs are a source of reactive
oxygen species
It has been established that P. falciparum-infected RBCs generate
ROS in the food vacuole and that the parasite-generated ROS
egresses into the host cell compartment [24,25]. To test whether P.
berghei ANKA-infected RBCs also produce ROS, we employed
dihydrorhodamine 123 (DHR), a cell-permeable fluorogenic
molecule used in the detection of peroxide and peroxynitrite
[30,31]. To determine the level of ROS production by iRBCs in
the peripheral circulation, blood was isolated from the tail veins of
WT mice 6 days after infection with a tdTomato-expressing PbA
strain (PbAtdT) and compared to uninfected controls (Figure 3A).
PbA-infected erythrocytes (ter119+ tdTomato+) exhibited a signif-
icantly higher DHR mean fluorescence compared to uninfected
RBCs (ter119+ tdTomato2) (Figure 3B) indicating that, similar to
P. falciparium blood stage parasites, PbA also generates ROS.
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In P. falciparum, erythrocytes containing trophozoites produce
the highest level of ROS [25]. To assess the contribution of ROS
production from schizont-infected RBCs sequestered within
pulmonary vessels [15], lungs from PbAtdT-infected animals were
extensively perfused to remove non-adherent cells prior to
analyzing sequestered iRBCs for ROS levels by DHR fluorescence
and flow cytometry. The iRBCs retained within the pulmonary
vasculature were positive for ROS production (Figure 3C). These
data demonstrate that iRBCs sequestered in the lung produce
ROS that could contribute to increased vascular permeability. Of
note, the level of ROS generated by the PbA schizont-infected
RBCs in the lungs was lower than that detected in the iRBCs from
the peripherial blood. Thus it appears that in PbA, like P.
falciparum, there is a stage-dependent production of ROS that
could serve to alter host responses.
CD36 contributes to ROS-induced barrier changes
To determine if ROS could contribute to the observed changes
in barrier function between WT and CD362/2 lungs, we
employed a mouse lung microvascular endothelial monolayer
(MLMVEC) system and measured the changes in transendothelial
resistance (TER) before and after ROS challenge. TER is
measured by passing a current across a cell monolayer and the
overall impedance provides an indicator of integrity of cellular
junctions. Basal TER was increased in CD362/2 MLMVECs
compared to WT suggesting an inherently tighter barrier in the
CD36-deficient MLMVEC (1098625 vs. 902626 V; N= 65–77;
P,0.0001). In WT MLMVEC monolayers, H2O2 caused a dose-
dependent decrease in TER during the first 30 minutes of
exposure (Figure 4A). At 1 mM H2O2, TER continued to drop
and remained low whereas the TER following 0.25 and 0.50 mM
H2O2 returned to baseline and then recovered to levels that were
significantly greater than that of untreated cells (Figure 4A). In
contrast, all H2O2 concentrations resulted in a rapid increase in
TER in the CD362/2 MLMVEC monolayers that remained
elevated with 0.25 and 0.50 mM H2O2 (Figure 4B). Following
1 mM exposure, the increased resistance of the CD362/2
MLMVEC gradually returned to baseline. These data uncover a
critical role for CD36 as a key mediator of ROS-induced
endothelial cell barrier dysfunction.
To assess whether the observed protection of CD362/2
endothelial cells to ROS-mediated endothelial barrier dysfunction
was due to enhanced antioxidant activity, we measured H2O2
scavenging and key antioxidant enzyme expression in WT and
CD362/2 MLMVECs. Despite the marked differences in TER
shown in Figure 4B, CD362/2 and WTMLMVECs scavenged a
similar amount of extracellular H2O2 across a range of H2O2
concentrations (Figure 5A). Furthermore, Western blot analysis of
three critical lung endothelial antioxidant enzymes, catalase,
glutathione peroxidase-1 (Gpx-1), and manganese superoxide
dismutase (MnSOD), revealed no differences between WT and
CD362/2 MLMVECs (Figure 5B). These data suggest that the
CD362/2 MLMVEC endothelial barrier protective properties
were not mediated by enhanced antioxidant scavenging of H2O2.
Figure 1. CD362/2 mice exhibit minimal malaria-induced lung pathology. A) Hematoxylin and eosin staining of histological lung sections
from control and P. berghei-infected (day 6) WT and CD362/2 mice (106). Inserts are representative higher-magnification fields (406) of the septal
thickening and edema seen in WT lungs compared to the lack of pathology in observed in the lungs from CD362/2 animals. B) Total number of cells
isolated from the bronchoalveolar lavage fluid from uninfected and P. berghei-infected WT and CD362/2 mice. Data are means 6 SE; n = 3–6.
*P,0.05 vs. Control;#P,0.05 vs. WT malaria by ANOVA interaction and Kruskal Wallace testing. C) P. berghei within lung conduit vessel (arrows) and
alveolar capillaries (arrowheads) of WT and CD362/2 mice (606). D) The number of P. berghei/high power field (HPF) in the alveolar capillaries or in
all vessels (Total) in the lungs of WT and CD362/2mice. Data are means6 SE. n = 3 mice per group and 10 HPFs per lung section.*P,0.05 vs. WT by
ANOVA.
doi:10.1371/journal.pone.0071010.g001
Figure 2. CD362/2 mice are protected from malaria-induced
endothelial permeability. A) Effect of P. berghei infection on
filtration coefficient in the lungs from WT and CD362/2 mice. Control
mice received 106 uninfected RBCs whereas malaria mice received 106
P. berghei-iRBCs. Filtration coefficient was measured on day 6 post-
injection as described in the Methods section. Data are means 6 SE.
n = 3–6; *P,0.02 vs. WT control; #P,0.05 vs. WT malaria by ANOVA
interaction. B) Effect of P. berghei infection on the average fluid
filtration in WT and CD362/2 mice. Average fluid filtration was
determined from the change in perfusion circuit hematocrit and a time-
weighted vascular pressure normalized to lung dry weight as described
in the Methods section. Data are means 6 SE. n = 3–6; *P,0.006 vs.
corresponding control; #P,0.002 vs. WT malaria by ANOVA interaction.
C) Effect of P. berghei infection on the albumin reflection coefficient
(salb) in the lungs from WT and CD362/2mice. salb was measured by a
modified filtered volume method as described in Methods. Data are
means 6 SE. n = 3–5; *P,0.005 vs. corresponding Control by ANOVA.
doi:10.1371/journal.pone.0071010.g002
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Fyn protein is dysregulated in CD362/2 MLMVECs
Because of a known association of CD36 with Fyn kinase in
dermal microvascular endothelial cells [17] and CD36-dependent
recruitment of activated Fyn [18], the distribution of Fyn in WT
and CD362/2 MLMVEC monolayers was determined
Figure 3. iRBCs generate reactive oxygen species (ROS) in the
peripheral blood and pulmonary vasculature. A) Flow cytometric
analysis of peripheral blood isolated from WT mice 6 days after
infection with P. berghei ANKA (left panel) or the red fluorescent strain
of P. berghei ANKA tdTomato (PbtdT) (right panel). The gating strategy
used to identify iRBCs based on tdTomato fluorescence forward scatter
(FSC) is defined in the right panel. B) ROS production in the peripheral
blood of control or PbAtdT-infected mice. ROS production was
measured by flow cytometry of cells isolated from control and
PbAtdT-infected (day 6) animals and labeled with dihydrorhodamine
(DHR) 123. Uninfected RBCs and iRBCs were separated based on the
presence of the erythroid marker, ter119, and PbAtdT fluorescence. The
data are expressed as mean fluorescence intensity (MFI) of the DHR 123.
Data are means 6 SE. n = 3–6; *P,0.001 vs. RBCs. Inset plot: histograms
of DHR fluorescence of peripheral unstained control RBCs (white
histogram), DHR-stained control RBCs (gray histogram), and DHR-
stained iRBCs (black histogram). C) ROS production of control or PbAtdT
iRBCs sequestered in the pulmonary vasculature. Lung-sequestered
RBCs were isolated via dispersion of lung tissue after vascular perfusion
with 10 ml of PBS to remove non-adherent cells. Lung-associated RBCs
and iRBCs were stained and sorted for the presence of the erythroid
marker, ter119, and PbAtdT fluorescence. Sorted cells were stained with
DHR 123 for assessment of ROS production. The data are expressed as
mean fluorescence intensity (MFI) of the DHR 123. Data are means6 SE.
n = 3–6; *P,0.001 vs RBCs. Inset plot: histograms of DHR fluorescence
of lung sequestered unstained control RBCs (white histogram), DHR-
stained control RBCs (gray histogram), and DHR-stained iRBCs (black
histogram).
doi:10.1371/journal.pone.0071010.g003
Figure 4. CD362/2 lung microvascular endothelial cells are
protected from increases in H2O2-induced endothelial barrier
permeability. Time course of trans-endothelial electrical resistance
(TER) of mouse lung microvascular endothelial cell (MLMVEC) mono-
layers from WT (A) or CD362/2 (B) mice following exposure to
increasing concentrations of H2O2 (0.25, 0.50 and 1.0 mM). All TER
values were normalized to the TER measured 0.5 h before the addition
of H2O2. Baseline TER for CD362/2 MLMVEC monolayers (1098625 V;
n = 63) was significantly greater (P,0.0001) than WT TER (902625 V;
n = 119). Data are means 6 SE. n = 16–26; all symbols indicate
P,0.00001 vs. diluent by 2-factor (H2O2 dose, time) ANOVA interaction;
* refers to 0.25 mM H2O2, + refers to 0.5 mM H2O2 and # refers to
1 mM H2O2). The result of a 3-factor (genotype, H2O2 dose, time)
ANOVA interaction F ratio was P,0.00001 for TER differing as a function
of CD36 expression.
doi:10.1371/journal.pone.0071010.g004
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(Figure 6A). In WT cells at baseline (top left), Fyn was present
throughout the cytoplasm in a focal adhesion-like pattern, but in
CD362/2 cells (top right), Fyn was predominantly peri-nuclear
with no concentration at focal adhesions or cell-cell interfaces.
After H2O2 challenge of WT MLMVECs, Fyn became strongly
co-localized with actin stress fibers. H2O2 challenge of CD362/2
MLMVEC monolayers resulted in no significant change in the
distribution of Fyn, which retained a diffuse peri-nuclear pattern.
Thus, CD36 deficiency was accompanied by a notable alteration
in the cellular distribution of Fyn in LMVECs suggesting that
altered Fyn-mediated signaling may play a role in the observed
changes in barrier function in CD362/2 lungs.
Fyn knockdown protects MLMVEC from changes in
paracellular permeability
To determine if disruption of Fyn-mediated signaling could
recapitulate the barrier function phenotype of CD362/2
monolayers, a sticky short interfering RNA (ssiRNA) approach
was employed to reduce the levels of Fyn in WT MLMVEC
monolayers prior to H2O2 challenge. Under the conditions used
here, ssiFyn decreased Fyn expression by ,33% (Figure 6B). This
level of Fyn knockdown had no demonstrable effect on baseline
TER (data not shown), but it did significantly increase the TER of
monolayers treated with 0.25 and 0.50 mM H2O2 when
compared to their respective scrambled ssiRNA (ssiScr) control
sequence groups (Figures 6C and 6D). At the 1 mM H2O2
challenge dose, the TER values for the ssiFyn-treated cells were
not significantly different from ssScr controls (data not shown).
The protective phenotype observed as a result of this partial
depletion of Fyn is consistent with the idea that CD36 signals via
Fyn to modulate paracellular permeability.
CD36 is critical for Fyn signaling in the lungs following
PbA infection
Based on evidence of Fyn dysregulation in CD362/2
MLMVECs, we examined the production of total, active (PY417-
Fyn) and inactive Fyn (PY528-Fyn) in lung homogenates from
control or day 6 post-PbA infected WT and CD362/2 mice.
Total Fyn protein levels were unchanged in malaria-infected WT
lungs compared to control, but significantly increased in PbA-
infected CD362/2 lungs compared to both control lungs and
infected WT lungs (Figures 7A and B). The increased Fyn levels in
CD362/2 lungs were largely inactive PY528-Fyn that was
significantly increased compared to WT mice. There was a
corresponding and significant decrease in the active PY417-Fyn in
CD362/2 mice compared to WT levels (Figures 7A, C and D).
The role Fyn plays in malaria-induced endothelial barrier
function was explored further using Fyn2/2 mice. PbA-infected
Fyn2/2 animals achieved parasitemia and exhibited morbidity/
mortality characteristics that were comparable to WT and
CD362/2 mice (Figure S1). The lungs from uninfected control
Fyn2/2 mice had similar baseline endothelial barrier parameters
to WT and CD362/22 controls (Figures 8A–8C). Malaria
infection in Fyn2/2 mice resulted in changes in Kf and Ff
(Figures 8A–8C) that were similar to that recorded for CD362/2
mice (Figure 2). Malaria infection decreased salb in both WT and
Fyn2/2 lungs but the decrease in Fyn2/2 did not reach
statistical significance. Of note, histological analysis of malaria-
infected Fyn 2/2 lungs revealed a lack of edema and septal
thickening comparable to that observed in CD362/2 lungs
(Figures 1A, 8D) despite having parasite numbers in the
pulmonary vasculature that were comparable to that observed in
the lungs from WT animals (Figure 8E). These data suggest that
iRBC-CD36-Fyn interactions are a major regulator of lung barrier
function during malaria infection. In addition, these data indicate
that, in the absence of the ability of CD36 to properly signal, ROS
Figure 5. WT and CD362/2 MLMVECs scavenge exogenous
H2O2 equally and display similar antioxidant enzyme expres-
sion. A) The dose-response relationship between increasing concen-
trations of H2O2 (20 mM, 50 mM, 100 mM) and the peak [H2O2] measured
by electrode (see Methods section) from WT and CD362/2 MLMVECs.
The peak [H2O2] values after 50 mM and 100 mM of H2O2 exposure were
normalized to the 20 mM H2O2 control value. Data are means 6 SE
(n = 4–5). B) Immunostained Western blots of catalase, glutathione
peroxidase 1 (Gpx-1) and manganese superoxide dismutase (MnSOD)
from extracts of WT and CD362/2 MLMVECs. The blots show the
results from four independent WT and four independent CD362/2
MLMVEC preparations. C) Quantitative analysis of the results of the
immunostained Western blots of catalase, glutathione peroxidase 1
(Gpx-1) and manganese superoxide dismutase (MnSOD). Antioxidant
enzyme expression was quantified by densitometry in arbitrary
densitometry units and normalized to GAPDH levels. Data are means
6 SE (n = 4–10).
doi:10.1371/journal.pone.0071010.g005
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produced by parasites have a minimal impact on paracellular
water conductance.
Discussion
It is well established that during severe malaria infection in
humans, parasite-containing erythrocytes adhere to pulmonary
capillary endothelium [2,32] and that this sequestration is
associated with ARDS in up to 25% of adults. P. flaciparium-
infected RBCs appear to use distributive interactions with CD36,
ICAM1, PCAM-1 and chondroitin sulfate A to adhere to vascular
endothelial cells [4,5]. In murine models of human malaria, CD36
on vascular endothelial cells is the major binding partner for
iRBCs [10,33,34]. The high level of CD36 expression in the lungs
[35] results in the sequestration of large numbers of iRBCs with an
attendant development of pulmonary inflammation and injury
[11]. A prominent feature of the lung pathology in humans and
mice is pulmonary edema, suggesting that CD36-iRBC interac-
tions could contribute directly or indirectly to alterations in
endothelial cell barrier integrity. The results reported here support
a mechanism in which iRBC interactions with CD36 initiates Fyn-
mediated signaling that leads to an alteration in endothelial cell
barrier function and pulmonary edema. In addition, our data
identify parasite- or host-derived ROS as a possible contributor to
this response.
P. berghei infection in WT animals resulted in .10-fold increase
in paracellular fluid conductance (Kf and Ff; Figures 2A, B) and a
marked decrease in the reflection coefficient (salb) indicating
failure of the endothelial mechanisms that exclude water and
plasma proteins from the lungs. In striking contrast, the lungs of
malaria-infected CD362/2 animals demonstrated significantly
decreased water conductance when compared to WT mice,
consistent with the observed lack of histological evidence of
pulmonary edema after malaria challenge (Figure 1). These results
Figure 6. Fyn cellular compartmentalization and the impact of Fyn knockdown on H2O2-mediated endothelial barrier function. A)
Effect of H2O2 exposure on WT (left panels) and CD362/2 (right panels) MLMVEC Fyn protein localization. MLMVECs stained for total Fyn (anti-Fyn,
green), actin (Texas red-conjugated phalloidin) and nuclei (DAPI 49, 6-diamidino-2-phenylindole, blue) without (top row) or with (bottom row) 60 min
of exposure to 500 mm H2O2 (606). Inserts show magnified images (1006). B) Efficiency of Fyn knockdown by sticky small interfering (ssi) RNA. Fyn
expression in WT MLMVECs 48 hours after transfection with lipofectamine only (Control), scrambled (ssiScr) or Fyn (ssiFyn) ssiRNA was assessed by
Western blot with quantification by densitometry. The data are expressed in arbitrary absorption units before normalization to GAPDH levels. Data
are means 6 SE. n = 3; *P,0.05 vs. ssScr. C, D) Time series of normalized trans-endothelial electrical resistance (TER) in WT MLMVEC monolayers
following exposure to (C) 0.25 mM or (D) 0.50 mM H2O2. Open symbols include Lipofectamine only, ssiScr and ssiFyn all in the absence of H2O2.
Closed symbols include ssiScr-transfected or ssiFyn-transfected MLMVEC monolayers exposed to H2O2. Data are means 6 SE. n = 3–5; *P,0.002 vs.
ssScr by ANOVA interaction.
doi:10.1371/journal.pone.0071010.g006
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support a mechanistic link between CD36-mediated sequestration
of iRBCs in the lungs and malaria-induced pulmonary para-
cellular hyperpermeability.
Interestingly, CD36 deficiency did not attenuate the malaria-
induced decrease in the reflection coefficient (salb). Recent evidence
suggests that the oncotic gradient is largely determined by the sieving
properties of the glycocalyx, a complex network of surface
glycopoproteins that covers the luminal surface of vascular
endothelial cells and extends into the intercellular clefts [19,36].
Thus, it is likely that the lowsalb frommalaria infection indicates loss
of glycocalyx integrity. This putative loss of the glycocalyx appears to
be a CD36-independent event, perhaps due to the activation of an
endogenous heparanase by circulating cytokines [37].
It is possible that the lack of change in vascular permeability
observed in the CD362/2 lungs during infection merely reflects a
lack of signaling due to the significantly reduced number of iRBCs
binding to the pulmonary vascular endothelium in the absence of
CD36 (Figure 1D). While we acknowledge this possibility, the
nearly identical permeability phenotype of Fyn2/2 lungs, where
CD36-dependent signaling capacity is presumably compromised
but the vascular endothelium binds near WT levels of iRBCs,
argues in favor of the interpretation that CD36-Fyn signaling is a
key regulator of barrier integrity during infection.
We have demonstrated previously that ROS can increase
pulmonary endothelial paracellular fluid permeability [23,38].
One possible source of ROS in malaria is the iRBC. The
degradation of hemoglobin in the food vacuole of a P. falciparum
iRBC produces free heme and ROS such as H2O2 and hydroxyl
radicals [24]. We report here for the first time that both circulating
and lung-sequestered P. berghei-infected erythrocytes also generate
ROS (Figures 3B and 3C). It is possible that the ROS generated
from immobilized schizont-containing RBCs (or ROS released
from non-sequestered iRBC as they pass through the lungs)
contributes to the disruption of lung barrier function. However,
the result that Fyn2/2 mice are protected from malaria-induced
paracellular hyperpermeability despite the presence of adhering
iRBCs suggests that the contribution of parasite-derived ROS to
the disruption of barrier function may be less important. It
remains to be determined the extent to which ROS produced from
iRBCs directly contributes to the malaria-induced increases in
vascular permeability.
Figure 7. Altered Fyn protein level and activation in the lungs of malaria-infected CD362/2 mice. A) Immunostained Western blots
measuring total Fyn, PY417-Fyn (activated form) and PY528-Fyn (inactivated form) in lung homogenates from control and malaria-infected (day 6) WT
and CD362/2 mice. B–D) Densitometry quantification of total Fyn (B), PY417-Fyn (C) and PY528-Fyn (D) normalized to actin expression. Data are
expressed in arbitrary densitometry units (ADU) normalized to WT control values and represent the mean 6 SE. n = 3–5; *P,0.05 vs. corresponding
control; #, P,0.05 vs. WT malaria by ANOVA interaction; +,P,0.03 vs. WT values by ANOVA main factor effect.
doi:10.1371/journal.pone.0071010.g007
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There are additional iRBC-related factors that may contribute
to the malaria-induced increase in fluid permeability. Macrophag-
es have been shown to be important in phagocytizing malaria-
infected RBCs in the spleen [39] and are implicated in controlling
the parasite load in the lungs [40]. It is possible that parasite-
activated macrophages or other inflammatory cells also produce
ROS to cause parasite killing [41]. In addition, Gillrie et al [42,43]
have shown that free merozoite proteins have an adverse effect on
microvascular endothelial permeability in vitro, suggesting that
rupturing of iRBCs in lung capillaries may play a role. Further
work is required to define the relative roles of CD36 ligation, ROS
and other parasite-derived factors in the adverse effects on the
pulmonary endothelial barrier.
The in vitro data in MLMVEC monolayers and the in vivo results
in malaria-infected lungs implicate Fyn kinase as a critical
downstream mediator of CD36-dependent lung endothelial
dysfunction. Fyn is known to regulate endothelial barrier function
[44] and to co-localize with the cytoplasmic domain of CD36 in
microvascular endothelial cells [17,18]. We found that Fyn was
recruited to and co-localized with the actin cytoskeleton in WT
MLMVEC treated with H2O2 (Figure 6A) similar to activated Src
[45]. In contrast, CD362/2 MLMVECs maintained a perinu-
clear localization and failed to recruit Fyn to the actin cytoskeleton
following H2O2 challenge (Figure 6A). Further evidence of Fyn
dysregulation in the absence of CD36 was obtained from malaria-
infected CD362/2 lungs where it was demonstrated that the
levels and activation status of Fyn were altered. The activity of Fyn
is controlled by dephosphorylation of Tyr528 which triggers
activation by autophosphorylation of Tyr417 [46]. We found that
Fyn protein levels were significantly increased in CD362/2
compared to WT lungs, but the increased Fyn was largely in the
inactive form (Figures 7A–D). Although the mechanism for this is
Figure 8. Fyn2/2 mice are protected from malaria-induced increases in pulmonary endothelial barrier permeability. A) Effect of P.
berghei infection on filtration coefficient in the lungs from WT and Fyn2/2 mice. Filtration coefficient was measured via isolated lung perfusion on
day 6 post-infection as described in the Methods. Data are means 6 SE. n = 3–6; *P,0.02 vs. corresponding control; #P,0.05 vs. WT malaria by
ANOVA interaction. B) Effect of P. berghei infection on the average fluid filtration in WT and Fyn2/2 mice. Average fluid filtration was determined
from the change in perfusion circuit hematocrit and a time-weighted vascular pressure normalized to lung dry weight as described in the Methods.
Data are means 6 SE. n = 3–6; *P,0.006 vs. corresponding control; #P,0.002 vs. WT malaria by ANOVA interaction. C) Effect of P. berghei infection
on the albumin reflection coefficient (salb) in the lungs from WT and Fyn2/2 mice. salb was measured by a modified filtered volume method as
described in Methods. Data are means 6 SE. n = 3–5; *P,0.01 vs. corresponding control by ANOVA main factor (malaria infection) effect. D)
Hematoxylin and eosin staining of histological lung sections from P. berghei-infected (day 6) Fyn2/2 mice (606). Circles identify P. berghei ANKA
within alveolar capillaries. E) The number of P. berghei/high power field (HPF) in the alveolar capillaries in the lungs of WT and Fyn2/2mice. Data are
means 6 SE. n = 3 mice per group and 10 HPFs per lung section.
doi:10.1371/journal.pone.0071010.g008
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unknown, we speculate that a physical association of Fyn with
CD36 may be required for Fyn activation perhaps because CD36
facilitates the interaction of Fyn with the phosphatase responsible
for dephosphorylating Tyr528.
Fyn2/2 mice were markedly protected from the PbA-induced
lung endothelial barrier dysfunction (Figure 8). The nearly
identical phenotype in the CD362/2 and Fyn2/2 mice
supports the hypothesis that CD36 and Fyn are functionally
linked in the mechanism that regulates pulmonary endothelial
barrier integrity in malaria. However, because Fyn has also been
shown to be important in T cell function [47–50], we cannot
exclude the possibility that a component of the phenotype
observed in vivo in the Fyn2/2 lungs was due to the effects of
an altered level of immune responsiveness. Additional studies are
planned to determine if there are significant changes in cytokine
response in Fyn2/2 animals and to what extent these changes
might contribute to the endothelial barrier protection.
In conclusion, this study is the first to show the critical roles that
CD36 and the tyrosine kinase Fyn play as mediators of the
increased pulmonary endothelial permeability found in malaria-
infected mice. In addition, these data suggest that CD36 is
necessary for the appropriate cellular compartmentalization and
activation of Fyn and that infection–induced ROS may serve as an
enhancing factor in the mechanism that results in pulmonary
edema. Although additional experiments are necessary to fully
elucidate these mechanisms, our data identify new potential targets
for future treatments of malaria-induced lung injury.
Materials and Methods
Ethics Statement
All animal protocols and procedures were approved by the
Johns Hopkins Animal Care and Use Committee (JHACUC). The
JHACUC and the University are fully in compliance with and
follow all applicable guidelines of the Animal Welfare Act
regulations and Public Health Service Policy. In addition, Johns
Hopkins maintains accreditation by the Association for the
Assessment and Accreditation of Laboratory Animal Care
International.
Animals
Wild-type (WT) male C57BL/6J mice and Fyn 2/2 mice on a
C57BL/6 background were purchased from the Jackson Labora-
tories (Bar Harbor, ME). CD362/2 mice on a C57BL/6
background were obtained from Dr. Maria Febbraio (Cleveland
Clinic Foundation) [51]. Both original congenic knockout mouse
strains were backcrossed .10 times into C57BL/6 mice. Mice
were maintained in a pathogen-free environment by the Johns
Hopkins Division of Comparative Medicine.
Parasites and infection
Plasmodium berghei ANKA (PbA) was obtained from The Malaria
Research and Reference Reagent Resource Center (MR4, ATCC,
Manassas, VA; P. berghei ANKA cl15cy1, catalog number MRA-
871). Transgenic P. berghei ANKA expressing the red fluorescent
protein tdTomato (PbAtdT) was obtained from Dr. Volker T.
Heussler (Bernard Nocht Institute, Hamburg, Germany) [52].
Parasite infectivity was standardized by sequential passage of a
frozen parasite stock through three C57BL/6J donor mice.
Asynchronous infections were established in test C57BL/6J mice
via intra-peritoneal (IP) injection of 106 iRBCs obtained from the
blood of the third donor. Control animals received 106 uninfected
RBCs IP. Starting on day 3 post-infection, parasitemia was
monitored by assessing Giemsa-stained thin blood smears.
Infection morbidity was assessed by measuring changes in body
weight (CS200 digital balance, Ohaus) and core temperature (TH-
5 thermometer, Physitemp).
Lung histology and BAL
On day 6 post-infection, mice were anesthetized with IP
administration of ketamine (150 mg/kg) and acetylpromazine
(15 mg/kg). The trachea was intubated and the mouse exsangui-
nated from the femoral artery. Following sternotomy, the
pulmonary vasculature was flushed with 2 ml of PBS through
the right ventricle. Right lung BAL cell counts and differentials
were determined as previously described [53]. The left lung was
instilled with 650 ml of 1% agarose in 4% paraformaldehyde at
37uC via the tracheal catheter and suspended in 4% paraformal-
dehyde for 48 hours. The lungs were embedded in paraffin [54]
and 10 mm sections were obtained from four levels. Hematoxylin
and eosin-stained sections were examined using a Nikon Eclipse
E800 microscope (Nikon Instruments, Melville, NY) and images
were acquired using SPOT RT charge-coupled device imager and
software (Spot Imaging Solutions, Sterling Heights, MI).
Isolated, perfused mouse lung
The isolated lung perfusion was performed as previously
described [55]. After anesthesia with ketamine and acetylproma-
zine, a tracheostomy was performed and room air ventilation
initiated with 6 ml/kg tidal volume, 120 breaths/minute and
3 mmHg positive end-expiratory pressure (MiniVent Mouse
Ventilator Type 845; Harvard Apparatus). After sternotomy,
cannulas were secured in the pulmonary artery and left heart. The
inspired gas was changed to 21% O2–5% CO2. The lungs were
perfused (2.5 ml/minute) with warmed (37uC) blood from day 6
infected or uninfected donor mice diluted to 15–20% hematocrit
with Brinster’s BMOC-3 media (Invitrogen 11126034) containing
3% Bovine Serum Albumin Fraction V (Sigma).
Pulmonary vascular permeability
The filtration coefficient (Kf) was measured as previously
described [55]. Briefly, left atrial pressure was increased from 10
to 40 mmHg in 5 mmHg increments at 15-minute intervals.
Perfusion was stopped when 40 mmHg was reached or if tracheal
edema occurred. The Kf was estimated from the slope of the
relationship between the change in reservoir weight over the final
5 minutes at each pressure and the mean pulmonary vascular
pressure normalized to lung dry weight. To allow a simultaneous
measurement of average fluid filtration (Ff) and the reflection
coefficient for albumin (salb), perfusate samples were collected for
measurement of hematocrit (Hct) and albumin concentration. Ff is
an estimate of the average rate of RBC-free fluid volume that left
the perfusate during the increase in pressure. Total filtered fluid
volume was calculated from the starting circuit volume and the
DHct. The filtered fluid volume was then divided by total filtration
time and a time-weighted vascular pressure normalized to lung dry
weight. Ff is unaffected by vascular volume change, circuit leakage
or lung hemorrhage. The salb was calculated via the filtered
volumes technique as previously described [56]. The right lung
was used for dry weight determination and the left lung was snap-
frozen and stored at 280uC.
Reactive oxygen species
Flow cytometry was employed to measure ROS production by
iRBCs. A strain of P. berghei ANKA that expresses the red
fluorescent protein tdTomato (PbAtdT) under the constitutively-
expressed eukaryotic elongation factor 1 alpha promoter was used
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[52]. Mice were infected with 1 million PbAtdT RBCs and
peripheral blood was collected 6 days post-infection directly into
FACS Buffer (1X PBS, 5% heat-inactivated FBS) and stored at
25uC in the dark prior to analysis. To isolate iRBC sequestered in
the pulmonary vasculature, on day-6 post-infection mice were
anaesthetized with 700 ml of 2, 2, 2-tribromoethanol (Sigma, St.
Louis, MO) and the lungs were perfused with 10 ml PBS via the
right ventricle to remove nonadherent iRBCs. The lungs were
excised, suspended in 5 ml RPMI 1640 containing 1 mg/ml
collagenase type II (Gibco) and 30 mg/ml DNase I (Roche) and
minced. Suspensions were passed through a 70-mm mesh nylon
cell strainer (BD Falcon) and the resulting cells pelleted at
1500 RPM (4uC) and washed twice in FACS Buffer. Pellets were
then suspended in 200 ml FACS buffer containing Fc Block (BD
Biosciences, San Jose, CA) and incubated on ice for 5 minutes.
Intracellular ROS was measured using dihydrorhodamine 123
(DHR) (Sigma) and erythrocytes were stained with APC-conju-
gated anti-mouse ter119 (eBioscience). Data were acquired on a
FACSCalibur flow cytometer using CellQuest software (BD
Biosciences). Data were analyzed using FloJo software (Tree Star).
Lung microvascular endothelial cell isolation and culture
Mouse lung microvascular endothelial cells (MLMVECs) were
isolated and purified as previously described [57]. Briefly, WT
C57BL/6 and CD362/2 mice were sacrificed by cervical
dislocation. Peripheral lung was rinsed with DMEM (Invitrogen),
minced, and digested in 1 ml of collagenase (1 mg/ml; Sigma) at
37uC for 20 minutes. The digest was filtered through sterile mesh
and centrifuged (400 g for 7 minutes). The pellet was suspended in
DMEM supplemented with 20% FBS, 150 mg/ml ECGS,
100 mg/ml penicillin/streptomycin, 0.25 mg/ml amphotericin B,
and placed in a 0.1% gelatin-coated T-25 flask. After reaching
confluence, the cells were stained overnight with acetylated LDL/
Alexa Fluor 488 conjugate (Molecular Probes/Invitrogen L23380),
an endothelial cell marker, and sorted into a purified endothelial
population using a FACS ARIA (Becton Dickinson). Endothelial
phenotype was confirmed by observing typical cobblestone
morphology and immunostaining for platelet endothelial cell
adhesion molecule and von Willebrand factor. All experiments
were performed with cells between passages 2 and 10.
Transendothelial electrical resistance (TER)
Measurement of TER was performed with ECIS Z Theta
(Applied BioPhysics,). Mouse lung microvascular cells from WT
C57BL/6 male mice and from CD362/2 male mice were grown
to confluence on 8w10e+ gold electrode plates in low serum media
(DMEM Low Glucose (Gibco) containing 1% FBS Heat
Inactivated; Sigma). Current was applied across the electrodes
with amplitude of 1 V in series with a resistance of 1 MV to
approximate a constant current source (,1 mA). The in-phase and
out-of-phase voltages between the electrodes were monitored and
converted to TER. Baseline resistance for each cell preparation
was measured just prior to experimental manipulation. The effect
of H2O2 at increasing concentrations (0.25 mM, 0.50 mM, or
1.0 mM) on TER was assessed over 2.5 hours.
MLMVEC H2O2 scavenging assessment
Real-time H2O2 concentrations were measured with an H2O2
electrode system (Apollo 4000 Free Radical Analyzer; World
Precision Instruments) as previously described [58]. Briefly, an
ISO-HPO-2 electrode was mounted in a multiport water-jacketed
sample chamber (NOCHM-4 Four-Port Closed Chamber, World
Precision Instruments). WT and CD362/2 MLMVECs were
washed twice with PBS, collected with trypsin, centrifuged, and
suspended in 2 ml of serum-free DMEM. The cell suspension was
warmed to 37uC and stirred before H2O2 was added to achieve a
specified concentration. The H2O2 signal was allowed to
completely decay before the next concentration of H2O2 was
added.
Immunofluorescence staining
MLMVECs were grown on gelatinized glass dishes before being
exposed to hydrogen peroxide. The cells were fixed in 4%
paraformaldehyde for 10 minutes, washed three times with Tris-
buffered saline solution containing 0.1% Tween 20 (TBS-T,
Sigma), permeabilized with 0.2% Triton X-100 in PBS for
5 minutes, and blocked with 2% BSA in PBS for 30 minutes.
MLMVECs were then stained with mouse anti-mouse Fyn (1:200,
Santa Cruz) for 1 hour followed by Alexa 488 goat anti-mouse
IgG (1:200, Molecular Probes) for 1 hour at room temperature.
Actin filaments were visualized by staining cells with Texas red-
conjugated phalloidin (Molecular Probe) in similar fashion. After
three washes with TBS-T, the coverslips were mounted with a
SlowFadeH AntiFade Kit (Molecular Probes) and analyzed using
an Olympus IX51 inverted fluorescent microscope (606 oil
objective) and a Cooke digital camera.
ssiRNA Fyn knockdown
The siRNA sequence targeting mouse Fyn was generated using
an siRNA design tool (www.ambion.com). Fyn-specific target
sequences were aligned to the mouse genome database in a
BLAST search to eliminate sequences with significant homology to
other mouse genes. Two mRNA targets common to all three
variants of mouse Fyn (NCBI Gene ID: 14360) were selected from
which sense and antisense oligonucleotides were synthesized
(Invitrogen). RNAs were transcribed from these oligonucleotides,
annealed to form double-stranded siRNA, and purified according
to the manufacturer’s instructions (Ambion, Austin, TX). Two
pairs of non-specific, non-silencing scramble (Scr) oligonucleotides
were also designed. Each pair of siFyn (or Scr) oligonucleotides
were then extended at their 59 end with short complementary
(dA)6/(dT)6 overhangs (Table S1) to generate sticky-siRNA
(ssiRNA). ssiRNAs are a new class of siRNAs designed to improve
stability, delivery and effectiveness [59]. MLMVEC were grown to
70% confluency in 12-well or ECIS culture plates and then serum-
starved for 1 hour in low serum media (DMEM Low Glucose
(Gibco) containing 1% FBS Heat Inactivated (Sigma)). For the 12-
well preparations, this was followed by incubation with 100 pmoles
(50 pmoles of each ssiRNA) of ssiFyn or ssScr. For ECIS
experiments, 60 pmoles (30 pmoles of each construct) ssiRNAs
were transfected per well. All transfections utilized Lipofectamine
2000 (Invitrogen) as a carrier. After 6 hours, complete media was
added (DMEM supplemented with 20% FBS) for 48 hours before
beginning each experiment.
Western blot analysis
Immunoblots for catalase (1:6000, Calbiochem), glutathione
peroxidase 1 (Gpx-1) (1 mg/ml, Abcam), manganese superoxide
dismutase (MnSOD) (1:100, Santa Cruz), Fyn (1:2000, Santa
Cruz), PY417-Fyn (1:1000, BD) and PY528-Fyn (1:1000, BD) in
MLMVEC or whole lung were performed as previously described
[60,61]. Briefly, MLMVECs were homogenized in lysis buffer
containing 150 mM NaCl, 1% Triton X-100, 20 mM Tris-HCl
(pH 7.4), 1006 protease inhibitor cocktail, 1 mM sodium vana-
date, 1 mM NaF, 1 mM PMSF (all from Sigma) for 30 minutes on
ice. Lungs were homogenized in 500 ml of tissue protein extraction
reagent (Thermo Scientific) with added 1006 protease inhibitor
cocktail, 1 mM Na3VO4, 1 mM NaF, and 1 mM PMSF in a
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FastPrep tubes containing lysing matrix beads (MP Biomedicals).
The homogenates were centrifuged, and the supernatants were
assayed for protein concentration by using a BCA protein assay kit
(Pierce). Soluble proteins (for lung homogenates 40 mg; for cell
homogenates 30 or 60 mg) were resolved on an 8% SDS-PAGE
(Bio-Rad) and transferred to polyvinylidene fluoride membrane
using the iBlot transfer system (Invitrogen). The membranes were
blocked with 5% BSA in Tris-buffered saline with 0.1% Tween-20
for 1 hour and then incubated with primary and secondary
horseradish peroxidase (HRP)-conjugated antibodies as previously
described. Equal protein loading was confirmed by stripping the
membranes (Restore Western Blot Stripping buffer, Thermo
Scientific) and reprobing with HRP-conjugated anti-Actin
(1:1,000, Abcam) or anti-GAPDH (1:25,000) antibodies. The blots
were developed with regular or enhanced chemiluminescence
(ECL or ECLplus; Amersham) and exposed to X-ray film (Kodak
BioMax MR). Bands of interest were quantified by densitometric
quantification using UN-SCAN-IT gel automated digitizing
system software version 5.1 (Silk Scientific).
Statistics
The effect of genotype on iRBC sequestration in malaria-
infected lungs and the comparison of ROS generation by RBC
and iRBC were analyzed by unpaired t tests. The effects of malaria
and genotype on pulmonary vascular permeability, H2O2
scavenging and antioxidant or Fyn protein expression were
analyzed by a 2-factor (genotype, malaria infection) ANOVA.
TER data were analyzed by either 2-factor (treatment, time) or 3-
factor (genotype, treatment and time) ANOVA with one repeated
measure. Non-normal data were converted to logarithms before
analysis. If logarithmic conversion proved insufficient to generate a
normal distribution by Kolmogorov–Smirnov testing, nonpara-
metric analysis was used. When a significant interaction F ratio
was obtained, least significant differences were calculated to allow
comparison of individual means. Values presented in the text are
means 6 SE. Differences were considered significant when
P#0.05.
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Supporting Information
Figure S1 Time course of body weight, temperature and
parasitemia kinetics are similar in WT, CD362/2 and
Fyn2/2 mice. The change in body weight (A), body
temperature (B) and parasitemia (C) of mice after receiving an
intraperitoneal injection of 106 P. berghei ANKA iRBCs. Weight
and temperature are expressed as the percentage change from the
weight or temperature at day 0. Data are presented as the means
6 SE (n= 10–24).
(TIF)
Figure S2 Flow cytometric assessment of parasite lung
accumulation in WT and CD362/2 mice. A) C57BL/6J
WT and CD362/2 mice were infected with a transgenic strain of
P. berghei ANKA that expressed the red fluorescent protein
tdTomato (PbA tdT). Lungs were perfused and isolated on
day 4 post-infection and sorted on tdTomato+ cells. The data are
representative of the results from 9 animals per group. Data were
acquired by running samples on a FACS Calibur flow cytometer
using CellQuest software (BD Biosciences, Mountain View, CA,
USA). Data were analyzed using FloJo software (Tree Star, Inc.,
Ashland, OR, USA). B) The number of PbAtdT-positive lung cells
in WT and CD362/2 lungs day 4 post-infection as determined
by flow cytometry. Data are presented as the means 6 SE of three
independent experiments (n = 9 mice per group) (P,0.001).
(TIF)
Table S1 Fyn ssiRNA oligonucleotide template sequenc-
es. Fyn-specific target (FYN) and non-specific, non-silencing
Scramble (Scr) oligonucleotides sequences of 1A and 2A are
shown. Each pair of small-interfering Fyn (siFYN) or small
Scramble (sScr) oligonucleotides were extended at their 59 end
with short complementary (dA)6/(dT)6 overhangs to generate
sticky-siFYN (ssiFYN) or sticky-sScr (ssScr) for concatemerization.
Further, all oligonucleotides were extended at their 39 end with
8 nt leader sequences that are complementary to T7 promoter
primer for RNA synthesis.
(DOCX)
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